Feder J N
Bristol-Myers Squibb Pharmaceutical Research Institute Princeton, NJ 08543-5400, USA.
Immunol Res. 1999;20(2):175-85. doi: 10.1007/BF02786472.
The iron overload disorder, hereditary hemochromatosis, is one of the most common genetic diseases of individuals of Northern European descent. The disorder is characterized by the progressive accumulation of dietary iron in the major organs of the body, which if not diagnosed, leads to numerous medical maladies and eventually death. The locus for this disorder was mapped by genetic linkage to the short arm of chromosome over twenty years ago, but it was not until 1996 that the gene for this disorder was cloned by an identity-by-descent positional cloning approach. The gene, called HFE, encodes a major histocompatibility complex (MHC) class I-like protein that is mutated in approx 85% of all individuals known to have hereditary hemochromatosis (HH). Since the cloning of the HFE gene, considerable work has been carried out which has furthered our understanding of the genetics of this prevalent disorder. In addition, with the identification of the transferrin receptor as a protein capable of interacting with HFE we are now beginning to understand how a protein with the structural characteristics of an MHC class I molecule can influence cellular iron homeostasis.
铁过载疾病——遗传性血色素沉着症,是北欧血统个体中最常见的遗传性疾病之一。该疾病的特征是膳食铁在身体主要器官中逐渐积累,如果不进行诊断,会导致多种疾病并最终死亡。二十多年前,通过遗传连锁分析将该疾病的基因座定位到染色体短臂上,但直到1996年,才通过基于同源性的定位克隆方法克隆出该疾病的基因。这个名为HFE的基因编码一种主要组织相容性复合体(MHC)I类样蛋白,在已知患有遗传性血色素沉着症(HH)的所有个体中,约85%的个体该蛋白发生了突变。自HFE基因克隆以来,已经开展了大量工作,这加深了我们对这种常见疾病遗传学的理解。此外,随着转铁蛋白受体被鉴定为一种能够与HFE相互作用的蛋白,我们现在开始了解具有MHC I类分子结构特征的蛋白如何影响细胞铁稳态。